Dr. Mariella Filbin Receives 2026 Emerging Leader Award from The Mark Foundation

he Mark Foundation for Cancer Research has named Dr. Mariella Filbin, Research Co-Director of the Pediatric Neuro-Oncology Program at Dana-Farber Cancer Institute, the recipient of the 2026 Emerging Leader Award, recognizing her innovative work to advance treatment options for aggressive childhood brain tumors.

By
January 14, 2026
2 min

Dana-Farber

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

#1

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Pediatric Neuro-Oncology
- Cancer Research
- Translational Medicine
#2

St. Jude Children's Research Hospital

Memphis, TN
Key Differentiators
- Pediatric Oncology
- Neuro-Oncology
- Genomic Medicine
#3

Children's Hospital of Philadelphia (CHOP)

Philadelphia, PA
Key Differentiators
- Pediatric Neuro-Oncology
- Cancer Biology
- Clinical Trials
#4

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Neuro-Oncology
- Cancer Research
- Pediatric Oncology

Dr. Mariella Filbin Receives 2026 Emerging Leader Award from The Mark Foundation

Top Institutions in Neurology

Dana-Farber Cancer Institute

St. Jude Children's Research Hospital

Children's Hospital of Philadelphia (CHOP)

Memorial Sloan Kettering Cancer Center

Original Source(s)

Dr. Mariella Filbin Receives 2026 Emerging Leader Award from The Mark Foundation

Related Content

Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countries

Circulating microRNA molecular signatures converge with erythroid phenotypes and iron homeostasis in pediatric tic disorders

Clinical GBM hybrid artificial intelligence for prescription dose recommendation and outcome prediction after gamma knife radiosurgery treatment: a proof-of-concept